Multiple activation states of receptors
Can receptors have different active states that selectively trigger certain effects? This has long been suspected. Now there is a proof.
Specific immune cells in autoimmune diseases
The immunology research team of ISAR Bioscience has developed methods to follow specific immune cells that are pivotal drivers of autoimmune disease.
ISAR Bioscience expands its manufacturing license and GMP certificate
ISAR Bioscience has expanded its manufacturing license for its premises in Planegg near Munich.
ISAR Bioscience at the EIC Summit 2025
Great recognition: Martha Sommer, team leader at ISAR Bioscience, has been invited to present the UniSens project at the Summit of the European Innovation Council on April 2, 2025.
Maria-Elena Torres-Padilla honoured with Leibniz Prize
ISAR Bioscience congratulates Maria-Elena Torres-Padilla, Member of the Board of the Foundation, on winning the Leibniz Prize 2025.
New member of the foundation’s board of directors
The foundation's board of trustees has appointed Dr. Barbara Krebs-Pohl to succeed Prof. Waldmann on the foundation's board of directors.
New member of the supervisory board
The foundation's board of trustees has appointed Angelika Leppert as a new member of the Supervisory Board.
New therapies for autoimmune diseases
ISAR Bioscience convinced a renowned funding agency with the GO-Immun project.
Regulatory authority gives green light for further development of an Alzheimer’s antibody
The Bavarian research company ISAR Bioscience is well on the way to a new Alzheimer's therapy.
ISAR Bioscience receives manufacturing authorisation and GMP Certificate
ISAR Bioscience has been granted a manufacturing authorisation in accordance with the German Medicines Act (§13 AMG) and a GMP (Good Manufacturing Practice) certification for its facility in [...]
